HDAX Therapeutics

Next-gen targeting for breakthrough medicines

General Information
Company Name
HDAX Therapeutics
Founded Year
2021
Location (Offices)
Mississauga, Canada +1
Founders / Decision Makers
Number of Employees
15
Industries
Biopharma, Biotechnology, Life Sciences +1
Funding Stage
Grant
Social Media

HDAX Therapeutics - Company Profile

HDAX Therapeutics is a biopharmaceutical and biotechnology startup that was founded in 2021. The company operates within the biopharma, biotechnology, and pharmaceutical industries. Known for its groundbreaking advancements in the field, HDAX Therapeutics received a significant Seed Round investment on September 28, 2022. The investment was made by FACIT, further solidifying the company's position as a promising venture in the biotech sector. With this recent investment, HDAX Therapeutics is poised for rapid growth and substantial contributions to the healthcare and biopharmaceutical industries.

Funding Rounds & Investors of HDAX Therapeutics (2)

View All
Funding Stage Amount No. Investors Investors Date
Grant $500.00K 1 Ministry of Economic Development, Job Creation and Trade 08 Jul 2024
Seed Round Unknown 1
FACIT, investor in HDAX Therapeutics's Seed Round round
28 Sep 2022

Latest News of HDAX Therapeutics

View All

No recent news or press coverage available for HDAX Therapeutics.

Similar Companies to HDAX Therapeutics

View All
EOM Pharmaceuticals - Similar company to HDAX Therapeutics
EOM Pharmaceuticals
Pioneer Gene - Similar company to HDAX Therapeutics
Pioneer Gene Advancing molecular diagnostics to enhance detection of genetic, tumor, and infectious diseases.
Chemtron Biotech Inc. - Similar company to HDAX Therapeutics
Chemtron Biotech Inc.
Neuron23 - Similar company to HDAX Therapeutics
Neuron23 We are a biotech company focused on developing precision medicines for neurological and immunological diseases.
SIWA Therapeutics - Similar company to HDAX Therapeutics
SIWA Therapeutics